National Institute of Neurological Disorders and Stroke awarded the team, including Jennifer Munson, associate professor at the Fralin Biomedical Institute at VTC, $3.75 million to study how fluid flow affects the success of CAR-T cell therapy on glioblastoma tumors.
Scientists from Virginia Tech, City of Hope aim to improve therapy for deadly brain cancer
